highly significantp < 0.01
We limited our analysis to highly significant pathways with a p < 0.01, which resulted in 25 and 17 pathways for ET and ET(H351A) treatment, respectively ( Table A1 ).
We limited our analysis to highly significant pathways with a p < 0.01, which resulted in 25 and 17 pathways for ET and ET(H351A) treatment, respectively ( Table A1 ).